Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Végvári Á[au]:

Mutant Proteogenomics. Végvári Á et al. Adv Exp Med Biol. (2016)

Novel insights in drug metabolism by MS imaging. Sugihara Y et al. Bioanalysis. (2016)

Large Scale Identification of Variant Proteins in Glioma Stem Cells. Mostovenko E et al. ACS Chem Neurosci. (2018)

Search results

Items: 1 to 50 of 91

1.

ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery.

Saei AA, Beusch CM, Chernobrovkin A, Sabatier P, Zhang B, Tokat ÜG, Stergiou E, Gaetani M, Végvári Á, Zubarev RA.

Nat Commun. 2019 Dec 16;10(1):5715. doi: 10.1038/s41467-019-13582-8.

2.

Malondialdehyde Conjugated With Albumin Induces Pro-Inflammatory Activation of T Cells Isolated From Human Atherosclerotic Plaques Both Directly and Via Dendritic Cell-Mediated Mechanism.

Rahman M, Steuer J, Gillgren P, Végvári Á, Liu A, Frostegård J.

JACC Basic Transl Sci. 2019 Jul 10;4(4):480-494. doi: 10.1016/j.jacbts.2019.03.009. eCollection 2019 Aug.

3.

Current status of clinical proteogenomics in lung cancer.

Nishimura T, Nakamura H, Végvári Á, Marko-Varga G, Furuya N, Saji H.

Expert Rev Proteomics. 2019 Sep;16(9):761-772. doi: 10.1080/14789450.2019.1654861. Epub 2019 Aug 21.

PMID:
31402712
4.

Deuteration of human carbonic anhydrase for neutron crystallography: Cell culture media, protein thermostability, and crystallization behavior.

Koruza K, Lafumat B, Végvári Á, Knecht W, Fisher SZ.

Arch Biochem Biophys. 2018 May 1;645:26-33. doi: 10.1016/j.abb.2018.03.008. Epub 2018 Mar 8.

5.

Large Scale Identification of Variant Proteins in Glioma Stem Cells.

Mostovenko E, Végvári Á, Rezeli M, Lichti CF, Fenyö D, Wang Q, Lang FF, Sulman EP, Sahlin KB, Marko-Varga G, Nilsson CL.

ACS Chem Neurosci. 2018 Jan 17;9(1):73-79. doi: 10.1021/acschemneuro.7b00362. Epub 2017 Dec 21.

6.

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors.

Torok S, Rezeli M, Kelemen O, Vegvari A, Watanabe K, Sugihara Y, Tisza A, Marton T, Kovacs I, Tovari J, Laszlo V, Helbich TH, Hegedus B, Klikovits T, Hoda MA, Klepetko W, Paku S, Marko-Varga G, Dome B.

Theranostics. 2017 Jan 1;7(2):400-412. doi: 10.7150/thno.16767. eCollection 2017.

7.

Relationship between HMF intake and SMF formation in vivo: An animal and human study.

Pastoriza de la Cueva S, Álvarez J, Végvári Á, Montilla-Gómez J, Cruz-López O, Delgado-Andrade C, Rufián-Henares JA.

Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600773. Epub 2016 Dec 20.

PMID:
27800655
8.

Mutant Proteogenomics.

Végvári Á.

Adv Exp Med Biol. 2016;926:77-91. Review.

PMID:
27686807
9.

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging.

Végvári Á, Shavkunov AS, Fehniger TE, Grabau D, Niméus E, Marko-Varga G.

Clin Transl Med. 2016 Mar;5(1):10. doi: 10.1186/s40169-016-0090-9. Epub 2016 Mar 10.

10.

Novel insights in drug metabolism by MS imaging.

Sugihara Y, Watanabe K, Végvári Á.

Bioanalysis. 2016 Mar;8(6):575-88. doi: 10.4155/bio-2015-0020. Epub 2016 Feb 26. Review.

PMID:
26915978
11.

Drug localizations in tissue by mass spectrometry imaging.

Végvári Á.

Biomark Med. 2015;9(9):869-76. doi: 10.2217/bmm.15.64. Epub 2015 Sep 2. Review.

PMID:
26328625
12.

Drug compound characterization by mass spectrometry imaging in cancer tissue.

Kwon HJ, Kim Y, Sugihara Y, Baldetorp B, Welinder C, Watanabe K, Nishimura T, Malm J, Török S, Döme B, Végvári Á, Gustavsson L, Fehniger TE, Marko-Varga G.

Arch Pharm Res. 2015 Sep;38(9):1718-27. doi: 10.1007/s12272-015-0627-2. Epub 2015 Jul 23. Review.

PMID:
26198812
13.

In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins.

Horvatovich P, Végvári Á, Saul J, Park JG, Qiu J, Syring M, Pirrotte P, Petritis K, Tegeler TJ, Aziz M, Fuentes M, Diez P, Gonzalez-Gonzalez M, Ibarrola N, Droste C, De Las Rivas J, Gil C, Clemente F, Hernaez ML, Corrales FJ, Nilsson CL, Berven FS, Bischoff R, Fehniger TE, LaBaer J, Marko-Varga G.

J Proteome Res. 2015 Sep 4;14(9):3441-51. doi: 10.1021/acs.jproteome.5b00486. Epub 2015 Jul 28.

PMID:
26155874
14.

Erratum to: Association of chromosome 19 to lung cancer genotypes and phenotypes.

Wang X, Zhang Y, Nilsson CL, Berven FS, Andrén PE, Carlsohn E, Horvatovich P, Malm J, Fuentes M, Végvári Á, Welinder C, Fehniger TE, Rezeli M, Edula G, Hober S, Nishimura T, Marko-Varga G.

Cancer Metastasis Rev. 2015 Jun;34(2):227. doi: 10.1007/s10555-015-9571-3.

PMID:
26143031
15.

Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project.

Horvatovich P, Lundberg EK, Chen YJ, Sung TY, He F, Nice EC, Goode RJ, Yu S, Ranganathan S, Baker MS, Domont GB, Velasquez E, Li D, Liu S, Wang Q, He QY, Menon R, Guan Y, Corrales FJ, Segura V, Casal JI, Pascual-Montano A, Albar JP, Fuentes M, Gonzalez-Gonzalez M, Diez P, Ibarrola N, Degano RM, Mohammed Y, Borchers CH, Urbani A, Soggiu A, Yamamoto T, Salekdeh GH, Archakov A, Ponomarenko E, Lisitsa A, Lichti CF, Mostovenko E, Kroes RA, Rezeli M, Végvári Á, Fehniger TE, Bischoff R, Vizcaíno JA, Deutsch EW, Lane L, Nilsson CL, Marko-Varga G, Omenn GS, Jeong SK, Lim JS, Paik YK, Hancock WS.

J Proteome Res. 2015 Sep 4;14(9):3415-31. doi: 10.1021/pr5013009. Epub 2015 Jul 23.

16.

Association of chromosome 19 to lung cancer genotypes and phenotypes.

Wang X, Zhang Y, Nilsson CL, Berven FS, Andrén PE, Carlsohn E, Horvatovich P, Malm J, Fuentes M, Végvári Á, Welinder C, Fehniger TE, Rezeli M, Edula G, Hober S, Nishimura T, Marko-Varga G.

Cancer Metastasis Rev. 2015 Jun;34(2):217-26. doi: 10.1007/s10555-015-9556-2. Review. Erratum in: Cancer Metastasis Rev. 2015 Jun;34(2):227.

PMID:
25982285
17.

Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging.

Connell JJ, Sugihara Y, Török S, Döme B, Tóvári J, Fehniger TE, Marko-Varga G, Végvári Á.

Anal Bioanal Chem. 2015 Mar;407(8):2245-53. doi: 10.1007/s00216-014-8350-2. Epub 2014 Nov 26.

PMID:
25424181
18.

Systematic identification of single amino acid variants in glioma stem-cell-derived chromosome 19 proteins.

Lichti CF, Mostovenko E, Wadsworth PA, Lynch GC, Pettitt BM, Sulman EP, Wang Q, Lang FF, Rezeli M, Marko-Varga G, Végvári Á, Nilsson CL.

J Proteome Res. 2015 Feb 6;14(2):778-86. doi: 10.1021/pr500810g. Epub 2014 Nov 25.

19.

Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome.

Nilsson CL, Mostovenko E, Lichti CF, Ruggles K, Fenyö D, Rosenbloom KR, Hancock WS, Paik YK, Omenn GS, LaBaer J, Kroes RA, Uhlén M, Hober S, Végvári Á, Andrén PE, Sulman EP, Lang FF, Fuentes M, Carlsohn E, Emmett MR, Moskal JR, Berven FS, Fehniger TE, Marko-Varga G.

J Proteome Res. 2015 Feb 6;14(2):603-8. doi: 10.1021/pr500564q. Epub 2014 Nov 26.

PMID:
25369122
20.

Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.

Torok S, Vegvari A, Rezeli M, Fehniger TE, Tovari J, Paku S, Laszlo V, Hegedus B, Rozsas A, Dome B, Marko-Varga G.

Br J Pharmacol. 2015 Feb;172(4):1148-63. doi: 10.1111/bph.12990. Epub 2015 Jan 12.

21.

A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging.

Sugihara Y, Végvári A, Welinder C, Jönsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, Wieslander E, Laurell T, Rezeli M, Jansson B, Nishimura T, Fehniger TE, Baldetorp B, Marko-Varga G.

Proteomics. 2014 Sep;14(17-18):1963-70. doi: 10.1002/pmic.201300476. Epub 2014 Aug 18. Review.

PMID:
25044963
22.

Aptamer/ISET-MS: a new affinity-based MALDI technique for improved detection of biomarkers.

Lee SJ, Adler B, Ekström S, Rezeli M, Végvári Á, Park JW, Malm J, Laurell T.

Anal Chem. 2014 Aug 5;86(15):7627-34. doi: 10.1021/ac501488b. Epub 2014 Jul 11.

PMID:
25001319
23.

Queries of MALDI-imaging global datasets identifying ion mass signatures associated with tissue compartments.

Fehniger TE, Suits F, Végvári Á, Horvatovich P, Foster M, Marko-Varga G.

Proteomics. 2014 Apr;14(7-8):862-71. doi: 10.1002/pmic.201300431.

PMID:
24478260
24.

Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage.

Malm J, Fehniger TE, Danmyr P, Végvári Á, Welinder C, Lindberg H, Upton P, Carter S, Appelqvist R, Sjödin K, Wieslander E, Dahlbäck M, Rezeli M, Erlinge D, Marko-Varga G.

Transl Respir Med. 2013 Dec;1(1):14. doi: 10.1186/2213-0802-1-14. Epub 2013 Aug 30.

25.

Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines.

Lichti CF, Liu H, Shavkunov AS, Mostovenko E, Sulman EP, Ezhilarasan R, Wang Q, Kroes RA, Moskal JC, Fenyö D, Oksuz BA, Conrad CA, Lang FF, Berven FS, Végvári A, Rezeli M, Marko-Varga G, Hober S, Nilsson CL.

J Proteome Res. 2014 Jan 3;13(1):191-9. doi: 10.1021/pr400786s. Epub 2013 Dec 3.

PMID:
24266786
26.

Accessing microenvironment compartments in formalin-fixed paraffin-embedded tissues by protein expression analysis.

Donnarumma F, Végvári Á, Rezeli M, Welinder C, Jansson B, Marko-Varga G.

Bioanalysis. 2013 Nov;5(21):2647-59. doi: 10.4155/bio.13.222.

PMID:
24180505
27.

Experimental models to study drug distributions in tissue using MALDI mass spectrometry imaging.

Végvári Á, Fehniger TE, Rezeli M, Laurell T, Döme B, Jansson B, Welinder C, Marko-Varga G.

J Proteome Res. 2013 Dec 6;12(12):5626-33. doi: 10.1021/pr400581b. Epub 2013 Nov 6.

PMID:
24134601
28.

Quantification of human kallikrein-2 in clinical samples by selected reaction monitoring.

Végvári A, Sjödin K, Rezeli M, Marko-Varga G.

J Proteome Res. 2013 Oct 4;12(10):4612-6. doi: 10.1021/pr400423k. Epub 2013 Sep 9.

PMID:
23978317
29.

Developments in biobanking workflow standardization providing sample integrity and stability.

Malm J, Fehniger TE, Danmyr P, Végvári A, Welinder C, Lindberg H, Appelqvist R, Sjödin K, Wieslander E, Laurell T, Hober S, Berven FS, Fenyö D, Wang X, Andrén PE, Edula G, Carlsohn E, Fuentes M, Nilsson CL, Dahlbäck M, Rezeli M, Erlinge D, Marko-Varga G.

J Proteomics. 2013 Dec 16;95:38-45. doi: 10.1016/j.jprot.2013.06.035. Epub 2013 Jul 13.

PMID:
23856607
30.

Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring.

Végvári A, Sjödin K, Rezeli M, Malm J, Lilja H, Laurell T, Marko-Varga G.

Mol Cell Proteomics. 2013 Oct;12(10):2761-73. doi: 10.1074/mcp.M113.028365. Epub 2013 Jul 10.

31.

Development of an MRM assay panel with application to biobank samples from patients with myocardial infarction.

Rezeli M, Végvári Á, Donnarumma F, Gidlöf O, Smith JG, Erlinge D, Marko-Varga G.

J Proteomics. 2013 Jul 11;87:16-25. doi: 10.1016/j.jprot.2013.05.016. Epub 2013 May 23.

PMID:
23707545
32.

Blood plasma reference material: a global resource for proteomic research.

Malm J, Danmyr P, Nilsson R, Appelqvist R, Végvári A, Marko-Varga G.

J Proteome Res. 2013 Jul 5;12(7):3087-92. doi: 10.1021/pr400131r. Epub 2013 May 30.

PMID:
23701512
33.

Correlation queries for mass spectrometry imaging.

Suits F, Fehniger TE, Végvári A, Marko-Varga G, Horvatovich P.

Anal Chem. 2013 May 7;85(9):4398-404. doi: 10.1021/ac303658t. Epub 2013 Apr 16.

PMID:
23537055
34.

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability.

Welinder C, Jönsson G, Ingvar C, Lundgren L, Olsson H, Breslin T, Végvári A, Laurell T, Rezeli M, Jansson B, Baldetorp B, Marko-Varga G.

Clin Transl Med. 2013 Feb 27;2(1):7. doi: 10.1186/2001-1326-2-7.

35.

Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine.

Marko-Varga G, Végvári A, Rezeli M, Prikk K, Ross P, Dahlbäck M, Edula G, Sepper R, Fehniger TE.

Clin Transl Med. 2012 May 31;1(1):8. doi: 10.1186/2001-1326-1-8.

36.

A critical evaluation of inflammatory markers in Huntington's Disease plasma.

Silajdžić E, Rezeli M, Végvári Á, Lahiri N, Andre R, Magnusson-Lind A, Nambron R, Kalliolia E, Marko-Varga G, Warner TT, Laurell T, Tabrizi SJ, Björkqvist M.

J Huntingtons Dis. 2013;2(1):125-34. doi: 10.3233/JHD-130049.

PMID:
25063434
37.

Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.

Nilsson CL, Berven F, Selheim F, Liu H, Moskal JR, Kroes RA, Sulman EP, Conrad CA, Lang FF, Andrén PE, Nilsson A, Carlsohn E, Lilja H, Malm J, Fenyö D, Subramaniyam D, Wang X, Gonzales-Gonzales M, Dasilva N, Diez P, Fuentes M, Végvári Á, Sjödin K, Welinder C, Laurell T, Fehniger TE, Lindberg H, Rezeli M, Edula G, Hober S, Marko-Varga G.

J Proteome Res. 2013 Jan 4;12(1):135-50. doi: 10.1021/pr3008607. Epub 2012 Dec 18.

38.

Clinical proteomics.

Végvári A, Kondo T, Marshall JG.

Int J Proteomics. 2012;2012:641491. doi: 10.1155/2012/641491. Epub 2012 Aug 15. No abstract available.

39.

Standardization and utilization of biobank resources in clinical protein science with examples of emerging applications.

Marko-Varga G, Végvári Á, Welinder C, Lindberg H, Rezeli M, Edula G, Svensson KJ, Belting M, Laurell T, Fehniger TE.

J Proteome Res. 2012 Nov 2;11(11):5124-34. doi: 10.1021/pr300185k. Epub 2012 May 25.

PMID:
22607352
40.

Large scale biobanking of blood - the importance of high density sample processing procedures.

Malm J, Végvári A, Rezeli M, Upton P, Danmyr P, Nilsson R, Steinfelder E, Marko-Varga G.

J Proteomics. 2012 Dec 5;76 Spec No.:116-24. doi: 10.1016/j.jprot.2012.05.003. Epub 2012 May 9.

PMID:
22580359
41.

Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.

Végvári Á, Rezeli M, Sihlbom C, Häkkinen J, Carlsohn E, Malm J, Lilja H, Laurell T, Marko-Varga G.

Clin Biochem. 2012 Mar;45(4-5):331-8. doi: 10.1016/j.clinbiochem.2011.11.018. Epub 2011 Dec 16.

42.

State-of-the-art MS technology applications in lung disease.

Végvári Á, Döme B.

Bioanalysis. 2011 Dec;3(23):2665-77. doi: 10.4155/bio.11.271. Review.

PMID:
22136054
43.

Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging.

Fehniger TE, Végvári A, Rezeli M, Prikk K, Ross P, Dahlbäck M, Edula G, Sepper R, Marko-Varga G.

Anal Chem. 2011 Nov 1;83(21):8329-36. doi: 10.1021/ac2014349. Epub 2011 Oct 7.

PMID:
21942412
44.

Biobank resources for future patient care: developments, principles and concepts.

Végvári A, Welinder C, Lindberg H, Fehniger TE, Marko-Varga G.

J Clin Bioinforma. 2011 Sep 16;1(1):24. doi: 10.1186/2043-9113-1-24.

45.

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels.

Rezeli M, Végvári A, Fehniger TE, Laurell T, Marko-Varga G.

J Clin Bioinforma. 2011 Feb 8;1(1):7. doi: 10.1186/2043-9113-1-7.

46.

Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples.

Végvári A, Rezeli M, Häkkinen J, Sihlbom C, Carlsohn E, Malm J, Lilja H, Laurell T, Marko-Varga G.

J Proteomics. 2011 Dec 10;75(1):202-10. doi: 10.1016/j.jprot.2011.06.008. Epub 2011 Jun 23.

47.

MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.

Rezeli M, Végvári A, Ottervald J, Olsson T, Laurell T, Marko-Varga G.

J Proteomics. 2011 Dec 10;75(1):211-20. doi: 10.1016/j.jprot.2011.05.042. Epub 2011 Jun 15.

PMID:
21703369
48.

Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging.

Marko-Varga G, Fehniger TE, Rezeli M, Döme B, Laurell T, Végvári A.

J Proteomics. 2011 Jun 10;74(7):982-92. doi: 10.1016/j.jprot.2011.03.019. Epub 2011 Apr 1.

PMID:
21440690
49.

Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer.

Végvári A, Marko-Varga G.

Chem Rev. 2010 May 12;110(5):3278-98. doi: 10.1021/cr100011x. Review. No abstract available.

PMID:
20415473
50.

Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry.

Végvári A, Fehniger TE, Gustavsson L, Nilsson A, Andrén PE, Kenne K, Nilsson J, Laurell T, Marko-Varga G.

J Proteomics. 2010 Apr 18;73(6):1270-8. doi: 10.1016/j.jprot.2010.02.021. Epub 2010 Mar 1.

PMID:
20193786

Supplemental Content

Loading ...
Support Center